The final mini-symposium at #IUCLS2024 on small molecule inhibitors concludes with a panel discussion discussing ongoing trials of this class of agents, with moderator Dr Vaishalee Kenkre and speakers Adam Kittai Kami Maddocks and Dr Changchun Deng
💥 A tour de force talk by MSKHemOncTrials Dr Zelenetz on key breakthroughs in his career & critical next steps to advance the field of #lymphoma (including import of National Comprehensive Cancer Network (NCCN) guidelines!). Thank you, Andy, for a great keynote! #IUCLS2024 Soni Smith MD Neha Mehta-Shah Tim Fenske
Keynote Presentation time! Co-chairs Soni Smith MD Andrew M. Evens, DO, MBA, MSc Neha Mehta-Shah and Tim Fenske award Andrew Zelenetz MD, PhD from Memorial Sloan Kettering Cancer Center with the Keynote Award before his talk on overcoming barriers to improve outcomes in lymphoma #IUCLS2024
Soni Smith MD giving wonderful historical perspective on Dr Ultmann’s legacy #IUCLS2024 Andrew M. Evens, DO, MBA, MSc Neha Mehta-Shah
We add some international flair to #IUCLS2024 as Stefano Luminari, MD from Italy discusses his approaches to treating older/elderly patients with newly diagnosed #DLBCL.
What was Lurie Cancer Center Leo Gordon walk-up song at the #IUCLS2024? See/hear below. 🧀🧀🧀 Leo moderated a great session w/ fantastic talks by Dana-Farber Ann LaCasce, MD on AYA lymphomas & UNIMORE Stefano Luminari, MD on older #lymphoma pts. Many important & unique considerations!
🙌 Great to have NJ colleagues Joanna M. Rhodes, MD, MSCE and Tara McCabe speak at the 21st annual #IUCLS2024 in Chicago and also to re-connect w/ our loved recent VP of cancer services at Rutgers Cancer Institute Robert Wood Johnson University Hospital, Kim Washington, now VP & CAO at UChicagoCancerCenter (uchicagomedicine.org/forefront/canc…). ⭕️
🎶🎸Rutgers Cancer Institute RWJBarnabas Dr Joanna M. Rhodes, MD, MSCE trying to psych out Mass General Cancer Center Dr Jacob Soumerai with her walk-up song on their debate on “Measuring MRD is the Standard of Care in CLL” at #IUCLS2024 Will CLL follow a similar path as multiple myeloma w/ MRD? BioAscend
4️⃣ Fabulous talks on impact of CPI in frontline Rx by Dr Hu, DEI in HL by Dr Kahn, current SOC for 1st relapse by Dr Rutherford, and who benefits most from radiation by MD Anderson Cancer Center Dr Pinnix. Beautiful slides and great discussion! #IUCLS2024
For the “duel” symposium at #IUCLS2024 Joanna M. Rhodes, MD, MSCE and Dr Jacob Soumerai from Mass General Cancer Center debate the role of MRD in #CLL. Do you think MRD is the standard of care in CLL?
The mini-symposium on Hodgkin lymphoma at #IUCLS2024 concludes with an esteemed panel of HL experts including moderator Andrew M. Evens, DO, MBA, MSc and speakers Justine Kahn MD, MS Chelsea C Pinnix MD PhD Dr Boyu Hu from Huntsman Cancer Institute and Dr Sarah Rutherford from WCM Lymphoma.
Day 2 of #IUCLS2024 opens with the DEI Keynote by Christopher Flowers from MD Anderson Cancer Center providing updates on strategies to reduce barriers that limit access to lymphoma care.
Day 1 of #IUCLS2024 concludes with a mini-symposium and panel focused on the management of bispecific antibodies with panelists Jennifer Crombie, MD David Russler-Germain, MD/PhD and L. Elizabeth Budde, M.D., Ph.D. with moderator Dr Reem Karmali of Northwestern Medicine.
🎶🎼 Walk up song for Siteman Cancer Center David Russler-Germain, MD/PhD @ #IUCLS2024 for great concluding day 1 mini-symposium on optimum use of bispecific Abs & CART in #lymphoma w/ Dana-Farber Dr Crombie & City of Hope Dr Budde, moderated by Lurie Cancer Center Dr Karmali (all risings 🌟🌟🌟🌟 in the field).
Superb discussion on bispecific antibodies in FL by David Russler-Germain, MD/PhD Agents leading to durable remissions for our patients with manageable toxicities and ? more exciting approvals to come. #IUCLS2024 WashUOncology Soni Smith MD Andrew M. Evens, DO, MBA, MSc Tim Fenske
Get out your microscopes! 📷 It’s time for the Hematopathology Tumor Board at #IUCLS2024 Andrew M. Evens, DO, MBA, MSc Girish Venkataraman and others discuss some of the challenges of diagnosing MYC/EBV+ lymphomas.
Management of advanced CTCL from Neha Mehta-Shah Siteman Cancer Center WashU Heme/Onc Fellowship WashUOncology at the #IUCLS2024
Co-chair Soni Smith MD opens the afternoon General Session with a mini-symposium on T-cell lymphoma, including talks on epigenetics by Enrica Marchi CTCL by Neha Mehta-Shah and regulatory implications by Dr Swaminathan Iyer from MD Anderson Cancer Center #IUCLS2024
